Document Detail


The impact of positive airway pressure on cardiac status and clinical outcomes in patients with advanced heart failure and sleep-disordered breathing: a preliminary report.
MedLine Citation:
PMID:  20890666     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
INTRODUCTION: Heart failure (HF) is a major public health problem associated with high rates of morbidity and mortality. Patients with HF exhibit a high prevalence of sleep-disordered breathing (SDB). We have investigated the long-term impact of positive airway pressure (PAP) therapy on heart function and clinical outcomes in patients with advanced HF and concomitant SDB.
MATERIALS AND METHODS: We assessed 18 patients with advanced HF (New York Heart Association (NYHA) functional classification III-IV) and concomitant SDB (diagnosed with polysomnography) either of obstructive or central type. Eleven patients who received PAP therapy (auto-titrating PAP or adaptive servo-ventilation) for 12 months were compared with seven patients who refused this therapy. All participants were assessed at both baseline and end of follow-up for NYHA functional status, left and right ventricular function, neurohormonal activation, and exercise tolerance. The rates of hospitalization, deaths, and the combination of both were also recorded.
RESULTS: Patients treated with PAP achieved better functional status, higher left ventricular ejection fraction, improved longitudinal right ventricular contractile function, lower levels of b-type natriuretic peptide, and greater exercise performance compared to those who remained untreated. PAP-treated group had a significantly lower incidence of the prespecified combined end-point (i.e., hospital admissions and death) than the control group (87.5 vs. 18.2%, p = 0.013). Interestingly, the mortality rate was 28% (two out of seven patients) in the control group, while no deaths were recorded in the PAP-treated group.
DISCUSSION: In this preliminary study, we found that treatment of SDB, irrespective of type, in stable patients with advanced HF receiving optimal medical therapy was associated with improvement in cardiac functional status, ventricular contraction, physical performance, and neurohormonal status, leading to better clinical outcomes.
Authors:
Apostolos Karavidas; Fotis Kapsimalis; George Lazaros; Evaggelos Markozanes; Sophia Arapi; Kiriaki Cholidou; Vassiliki Matzaraki; Konstantina Kyrkou; Dimitris Tsiachris; Evaggelos Matsakas; Vlassios Pyrgakis; Manos Alchanatis
Related Documents :
16363316 - Acute renal failure following open heart surgery: risk factors and prognosis.
23168216 - The changing pattern of bacterial meningitis in adult patients at a large tertiary univ...
18371486 - Clinical response of cardiac resynchronization therapy in the elderly.
8483066 - Aminocaproic acid decreases the incidence of intracranial hemorrhage and other hemorrha...
21221666 - Assessment of adjacent-segment mobility after cervical disc replacement versus fusion: ...
21795066 - Early aggressive medical management for patients with symptomatic intracranial stenosis.
Publication Detail:
Type:  Journal Article     Date:  2010-10-02
Journal Detail:
Title:  Sleep & breathing = Schlaf & Atmung     Volume:  15     ISSN:  1522-1709     ISO Abbreviation:  Sleep Breath     Publication Date:  2011 Dec 
Date Detail:
Created Date:  2011-11-07     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9804161     Medline TA:  Sleep Breath     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  701-9     Citation Subset:  IM    
Affiliation:
Department of Cardiology, Athens General Hospital, Achilleos 31, P. Faliron, 115 27, Athens, Greece.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  In situ labeling and magnetic resonance imaging of transplanted human hepatic stem cells.
Next Document:  Accumulation of CD1a-positive Langerhans cells and mast cells in actinic cheilitis.